Sophia Lee
Chemotherapy, radiation, targeted therapy, and immunotherapy have given cancer patients new hope. As cancer patient survival rates and clinical experience have expanded, interest in cancer therapy-induced cardiovascular disease has grown. To create effective preventative and treatment measures for the side effects of cancer treatments that can be deadly or result in long-term morbidity, a deeper understanding of the molecular biology underlying the disease is required. In addition to the typical cardio-protection drugs, traditional Chinese medicine formulations are efficient and can be expected to achieve "tailored treatment" from a range of perspectives. Also highlighting the urgent need for collaboration between cardiologists and oncologists is the emergence of "reverse cardio-oncology" as a result of the increased incidence of cancer in persons with cardiovascular disease.
分享此文章
English 
Spanish 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 